About DigiTx Partners
DigiTx Partners is a venture capital firm founded in 2016. It is primarily based out of Brisbane, United States. As of Jul 2026, DigiTx Partners is an active investor, having invested in 24 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from HealthTech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Seed round of Biobase Overall, DigiTx Partners portfolio has seen 1 acquisition, namely Tissue Analytics. A lot of funds co-invest with DigiTx Partners, with names like PBJ Capital sharing a substantial percentage of its portfolio. DigiTx Partners has team of 4 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 1 more
Portfolio Acquisitions
Deals in last 12 months
DigiTx Partners' List of Top Investments
DigiTx Partners has a portfolio of 24 companies. Their most notable investments are in Siris Medical and Tissue Analytics.Their portfolio spans across United States, Canada and Finland. They have invested in HealthTech, Enterprise Applications, Life Sciences and 6 other sectors, across stages such as Series A, Seed and 1 more. Here is the list of top investments by DigiTx Partners:
1. Eko
Eko offers an AI-based platform for remote monitoring of cardiac health. The solution offered by the company collects real-time patient data and analyses it to generate a report for doctors. The report generated aids in providing proper treatment to patients. The company has also developed products like Duo and Core stethoscopes for heart disease monitoring.
Key facts about Eko
- Founded Year: 2012
- Location: Oakland (United States)
- Stage: Series D
- Total Funding till date: $195M
- Employee Count: 205 as on Jun 30, 2026
- Investors: 10x Group, EDBI and 34 Others
- Latest Funding Round: Grant (prize money), Apr 11, 2025, $*****
- Highlight: Editors' Pick
2. Welldoc
WellDoc’s flagship product, BlueStar, is a Mobile Prescription Therapy that enables patients to self-manage their diabetes through real-time motivational, behavioral, and educational coaching. Personalized coaching is provided using patented algorithms and real-time analysis of patient diabetes data. BlueStar requires a prescription from a licensed healthcare provider and can be dispensed and reimbursed through a pharmacy.
Key facts about Welldoc
- Founded Year: 2005
- Location: Columbia (United States)
- Stage: Series B
- Total Funding till date: $82.1M
- Employee Count: 394 as on Jun 30, 2026
- Investors: Hudson River Capital Partners, Adage Capital Management and 13 Others
- Latest Funding Round: Series B, Mar 01, 2016, $*****
- Highlight: Editors' Pick
3. Cleerly
Provider of an AI-driven platform for coronary artery disease assessment. The platform quantifies atherosclerosis by measuring plaque volume, composition, length, and location. It evaluates stenosis severity and determines the likely presence or absence of ischemia. The software aims to reduce the need for additional testing and enhance diagnostic confidence.
Key facts about Cleerly
- Founded Year: 2016
- Location: Denver (United States)
- Stage: Series C
- Total Funding till date: $578M
- Employee Count: 359 as on Jun 30, 2026
- Investors: T. Rowe Price, Insight Partners and 20 Others
- Latest Funding Round: Series C, Nov 19, 2024, $*****
- Highlight: Editors' Pick
4. EMBR labs
Provider of a wearable device for monitoring body temperature. The device offers cooling and warming sensations through a wristband. It utilizes thermal waves to stimulate temperature sensitive nerves. The device is designed to provide relief for thermal discomfort. The related mobile application allows users to personalize the experience. The device is worn on the wrist, which is an area of blood flow, and cools or warms the body at a rate of about 0.4 degrees Celsius per second. The prototype consists of a copper alloy based heat sink and a system to control thermal impulses.
Key facts about EMBR labs
- Founded Year: 2014
- Location: Boston (United States)
- Stage: Series B
- Total Funding till date: $15M
- Employee Count: 18 as on Jun 30, 2026
- Investors: Bose Ventures, Aon and 14 Others
- Latest Funding Round: Series B, Oct 16, 2024, $*****
- Highlight: Editors' Pick
5. Rune Labs
Rune Labs provides a software-as-a-service platform with neuromodulation systems. The platform helps in managing therapies with the help of data.
Key facts about Rune Labs
- Founded Year: 2018
- Location: San Francisco (United States)
- Stage: Series B
- Total Funding till date: $56.5M
- Employee Count: 37 as on Jun 30, 2026
- Investors: Eclipse, TruVenturo and 8 Others
- Latest Funding Round: Series B, Jun 13, 2025, $*****
- Highlight: Editors' Pick
DigiTx Partners' Year-on-Year Investment Trends
DigiTx Partners has invested in 24 companies over the last 9 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 1 investment, while as of Jul 2026, it has made 1 investment in this year. Its most recent first time investment was in Biobase and most recent follow-on round was in Rune Labs.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 1 | 0 | 1 |
2024 | 3 | 1 | 4 |
2023 | 2 | 0 | 2 |
2022 | 0 | 2 | 2 |
2021 | 4 | 1 | 5 |
2020 | 1 | 1 | 2 |
2019 | 3 | 1 | 4 |
2018 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
DigiTx Partners' Investments by Stage
DigiTx Partners has made 9 investments in Series A stage with an average round size of $10M, 5 investments in Seed stage with an average round size of $5.16M and 4 investments in Series B stage with an average round size of $21.5M.Stage of entry | No. of Investments |
|---|---|
Series A | 9 |
Seed | 5 |
Series B | 4 |
Note: We have considered here, only first round of investments
DigiTx Partners' Investments by Sector
DigiTx Partners has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Life Sciences, High Tech and Vertical SaaS. Notably, it has invested in 23 Tech companies, 17 Enterprise (B2B) companies, 17 Software companies and at least 7 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
HealthTech | 14 |
Enterprise Applications | 9 |
Life Sciences | 6 |
High Tech | 4 |
Vertical SaaS | 4 |
Others | 10 |
Note: We have considered here, only first round of investments
DigiTx Partners' Investments by Geography
DigiTx Partners has made most investments in United States (15), followed by Canada where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 15 |
Canada | 1 |
Finland | 1 |
Note: We have considered here, only first round of investments
DigiTx Partners' recent investments
DigiTx Partners has made 1 investments in 2026 so far - Biobase.Here are the most recent investments by DigiTx Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 08, 2026 | United States | Seed | 6549 | [+1] | |
Feb 11, 2025 | - | Seed | 4725 | [+4] | |
May 23, 2024 | United States | Seed | 3695 | ||
May 08, 2024 | United States | Series A | 4253 | [+2] | |
Jan 23, 2024 | Finland | Series A | 5644 | [+1] |
Acquired companies in DigiTx Partners' Portfolio
1 company from DigiTx Partners' portfolio has been acquired. The most recent acquisition was Tissue Analytics in Apr 2020 by Net Health for $*****.Here are DigiTx Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 01, 2020 | Jan 16, 2018 | Series A | 9153 |
Team profile of DigiTx Partners
DigiTx Partners has a team of 4 members including 2 Partners and 1 Principal located in United States and United Kingdom. DigiTx Partners' team does not sit on the board of any company as of now.Here is a list of all team members in DigiTx Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Francisco | - | - | |
Partner | Addlestone | - | - | |
Principal | San Francisco | - | - |
Co-investors of DigiTx Partners
Over the past 9 years, 105 investors have co-invested in DigiTx Partners's portfolio companies. This includes funds and angels.
- Invested before DigiTx Partners: Dreamit, FOUNDER.org and 34 others have invested in rounds before DigiTx Partners. There are 2 companies where Dreamit has invested before DigiTx Partners and 1 company where FOUNDER.org has invested before DigiTx Partners.
- Top Co-investors of DigiTx Partners: 40 investors entered a company along with DigiTx Partners. These include investors like PBJ Capital (2 companies).
- Invested after DigiTx Partners: A total of 29 investors have invested in DigiTx Partners's portfolio after their investments. Top Investors include Highland Capital Partners (1 company), Questa Capital (1 company) and Peak XV Partners (1 company).
Recent News related to DigiTx Partners
•
Auxira Health Secures $7.8M to Address Cardiology Shortage with Virtual Clinical PodsHIT Consultant•Dec 16, 2025•Route 66 Ventures, Auxira, MedStar Health, Ensemble Innovation Ventures and 4 others
•
Cerula Care Raises $3.7 Million Oversubscribed Seed Round to Transform Collaborative Behavioral Healthcare for Oncology Patientsintelligence360•Feb 25, 2025•Cerula Care, Amplify Capital, BrightEdge, DigiTx Partners and 1 other
•
Latham & Watkins Advises Cerula Care in US$3.7 Million Seed FinancingLegal Desire•Feb 15, 2025•Latham & Watkins, Cerula Care, Esplanade Ventures, Amplify Capital and 3 others
•
Cerula Care raises $3.7M seed round to support cancer patients’ mental healthEndPoints News•Feb 12, 2025•Cerula Care, Esplanade Ventures, Amplify Capital, BrightEdge and 5 others
•
Embr Labs has filed a notice of an exempt offering of securities to raise $6 Million in New Equity Investment.intelligence360•Nov 06, 2024•EMBR labs, DigiTx Partners, Safar Partners, Bose Ventures and 1 other
•
•
Ciba Health Raises $10M to Reverse Chronic Diseases Through Root-Cause TreatmentHIT Consultant•May 08, 2024•Ciba Health, Plug and Play Tech Center, Third Culture Capital, E12 Ventures and 1 other
•
CardioSignal Raises $10 Million in Series A FinancingMedical Product Outsourcing•Mar 26, 2024•CardioSignal, Maki, DigiTx Partners
•
•
Rune Labs Unveils $12 Million Strategic Round to Accelerate Adoption of Novel Parkinson’s TechnologiesBusiness Wire•Jan 11, 2024•Rune Labs, Nexus NeuroTech Ventures, DigiTx Partners, Moment Ventures and 4 others
